vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Enpro Inc. (NPO). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $207.8M, roughly 1.4× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -10.8%, a 68.2% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
IDYA vs NPO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $295.4M |
| Net Profit | $119.2M | $-32.0M |
| Gross Margin | — | 42.1% |
| Operating Margin | 52.2% | 11.2% |
| Net Margin | 57.4% | -10.8% |
| Revenue YoY | — | 14.3% |
| Net Profit YoY | 330.1% | -330.2% |
| EPS (diluted) | $1.33 | $-1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.4M | ||
| Q3 25 | $207.8M | $286.6M | ||
| Q2 25 | — | $288.1M | ||
| Q1 25 | — | $273.2M | ||
| Q4 24 | — | $258.4M | ||
| Q3 24 | $0 | $260.9M | ||
| Q2 24 | $0 | $271.9M | ||
| Q1 24 | $0 | $257.5M |
| Q4 25 | — | $-32.0M | ||
| Q3 25 | $119.2M | $21.6M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | — | $24.5M | ||
| Q4 24 | — | $13.9M | ||
| Q3 24 | $-51.8M | $19.8M | ||
| Q2 24 | $-52.8M | $26.7M | ||
| Q1 24 | $-39.6M | $12.5M |
| Q4 25 | — | 42.1% | ||
| Q3 25 | — | 41.9% | ||
| Q2 25 | — | 43.3% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 42.3% | ||
| Q3 24 | — | 42.3% | ||
| Q2 24 | — | 43.8% | ||
| Q1 24 | — | 41.2% |
| Q4 25 | — | 11.2% | ||
| Q3 25 | 52.2% | 14.3% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 17.7% | ||
| Q1 24 | — | 10.9% |
| Q4 25 | — | -10.8% | ||
| Q3 25 | 57.4% | 7.5% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 7.6% | ||
| Q2 24 | — | 9.8% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | $-1.50 | ||
| Q3 25 | $1.33 | $1.01 | ||
| Q2 25 | — | $1.25 | ||
| Q1 25 | — | $1.15 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | $-0.60 | $0.94 | ||
| Q2 24 | $-0.68 | $1.27 | ||
| Q1 24 | $-0.53 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $114.7M |
| Total DebtLower is stronger | — | $655.3M |
| Stockholders' EquityBook value | $1.1B | $1.5B |
| Total Assets | $1.2B | $2.7B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $114.7M | ||
| Q3 25 | $786.9M | $132.9M | ||
| Q2 25 | — | $107.1M | ||
| Q1 25 | — | $240.3M | ||
| Q4 24 | — | $236.3M | ||
| Q3 24 | $920.0M | $206.9M | ||
| Q2 24 | $701.7M | $175.9M | ||
| Q1 24 | $698.8M | $163.9M |
| Q4 25 | — | $655.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $640.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $644.9M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $931.7M | $1.4B | ||
| Q1 24 | $935.3M | $1.4B |
| Q4 25 | — | $2.7B | ||
| Q3 25 | $1.2B | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | $1.2B | $2.5B | ||
| Q2 24 | $973.7M | $2.5B | ||
| Q1 24 | $961.5M | $2.5B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | — |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | 4.1% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | $65.3M | ||
| Q2 25 | — | $52.2M | ||
| Q1 25 | — | $21.0M | ||
| Q4 24 | — | $59.4M | ||
| Q3 24 | $-49.2M | $54.0M | ||
| Q2 24 | $-32.9M | $43.2M | ||
| Q1 24 | $-43.8M | $6.3M |
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | $53.4M | ||
| Q2 25 | — | $42.3M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $49.1M | ||
| Q3 24 | $-49.7M | $48.3M | ||
| Q2 24 | $-33.9M | $38.3M | ||
| Q1 24 | $-45.1M | $-1.9M |
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | 18.6% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 19.0% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | — | 14.1% | ||
| Q1 24 | — | -0.7% |
| Q4 25 | — | 4.1% | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 3.02× | ||
| Q2 25 | — | 1.98× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 4.27× | ||
| Q3 24 | — | 2.73× | ||
| Q2 24 | — | 1.62× | ||
| Q1 24 | — | 0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
